Literature DB >> 16958831

Cord blood transplantation for adults.

Claudio G Brunstein1, John E Wagner.   

Abstract

Allogeneic haematopoietic stem cell transplant has become an import tool for the treatment of high risk and advanced haematological diseases. However, allogeneic transplantation has been limited by the availability of suitable related and unrelated donors. The positive results with umbilical cord blood as an alternative source of haematopoietic stem cells for transplantation in the paediatric setting encouraged studies in adult patients. In adults, however, the progress of cord blood transplantation has been slower, in part limited by the limitation of cell dose. We review here the current state of the art on cord blood transplantation for adults, and discuss some of the newer strategies being pursued in order to improve its safety and efficacy.

Entities:  

Mesh：

Year:  2006        PMID： 16958831     DOI： 10.1111/j.1423-0410.2006.00823.x

Source DB:  PubMed          Journal:  Vox Sang        ISSN： 0042-9007            Impact factor:   2.144


  9 in total

1.  Role of Chk1 in the differentiation program of hematopoietic stem cells.

Authors:  Laura Carrassa; Elisa Montelatici; Lorenza Lazzari; Stefano Zangrossi; Matteo Simone; Massimo Broggini; Giovanna Damia
Journal:  Cell Mol Life Sci       Date:  2010-02-10       Impact factor: 9.261

2.  The Mannheim Cord Blood Bank: Experiences and Perspectives for the Future.

Authors:  Stephanie Lauber; Monika Latta; Harald Klüter; Michael Müller-Steinhardt
Journal:  Transfus Med Hemother       Date:  2010-03-15       Impact factor: 3.747

3.  Four phases of checks for exclusion of umbilical cord blood donors.

Authors:  Gennaro Volpe; Michele Santodirocco; Lazzaro Di Mauro; Giuseppe Miscio; Filippo Maria Boscia; Brunella Muto; Nicola Volpe
Journal:  Blood Transfus       Date:  2011-04-07       Impact factor: 3.443

4.  Osteogenic Commitment of MSC Is Enhanced after Interaction with Umbilical Cord Blood Mononuclear Cells In Vitro.

Authors:  E R Andreeva; M I Ezdakova; P I Bobyleva; I V Andrianova; A Yu Ratushnyy; L B Buravkova
Journal:  Bull Exp Biol Med       Date:  2021-09-20       Impact factor: 0.804

5.  Comparison of cyclosporine and tacrolimus combined with mycophenolate mofetil in prophylaxis for graft-versus-host disease after reduced-intensity umbilical cord blood transplantation.

Authors:  Toshihiro Miyamoto; Shuichiro Takashima; Koji Kato; Ken Takase; Goichi Yoshimoto; Shuro Yoshida; Hideho Henzan; Koichi Osaki; Tomohiko Kamimura; Hiromi Iwasaki; Tetsuya Eto; Takanori Teshima; Koji Nagafuji; Koichi Akashi
Journal:  Int J Hematol       Date:  2016-09-29       Impact factor: 2.490

6.  'Not taken in by media hype': how potential donors, recipients and members of the general public perceive stem cell research.

Authors:  V L Peddie; M Porter; C Counsell; L Caie; D Pearson; S Bhattacharya
Journal:  Hum Reprod       Date:  2009-01-24       Impact factor: 6.918

7.  Enhanced engraftment of a very low-dose cord blood unit in an adult haemopoietic transplant by addition of six mismatched viable cord units.

Authors:  Stephen J Proctor; Catherine E Chapman; Rachel Sharples; Helen L Lucraft; Jennifer Wilkinson; Jane Conn; Peter G Middleton
Journal:  Stem Cells Int       Date:  2009-08-26       Impact factor: 5.443

8.  Mesenchymal stromal cells' role in tumor microenvironment: involvement of signaling pathways.

Authors:  Armel Herve Nwabo Kamdje; Paul Takam Kamga; Richard Tagne Simo; Lorella Vecchio; Paul Faustin Seke Etet; Jean Marc Muller; Giulio Bassi; Erique Lukong; Raghuveera Kumar Goel; Jeremie Mbo Amvene; Mauro Krampera
Journal:  Cancer Biol Med       Date:  2017-05       Impact factor: 4.248

9.  Nov/CCN3 Enhances Cord Blood Engraftment by Rapidly Recruiting Latent Human Stem Cell Activity.

Authors:  Rajeev Gupta; Virginia Turati; Duncan Brian; Craig Thrussel; Barry Wilbourn; Gillian May; Tariq Enver
Journal:  Cell Stem Cell       Date:  2020-03-19       Impact factor: 24.633
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.